Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Assay and Drug Development Technologies|April 20, 2004
G protein-coupled receptor desensitization as a measure of signaling: modeling of arrestin recruitment to activated CCK-B receptorsLarry S Barak, Robert H Oakley, Michael A ShetzlineSouthern Medical Journal|January 24, 2003
Gastrointestinal bleeding in adult patients with Meckel's diverticulum: the role of technetium 99m pertechnetate scanSauyu Lin, Paul V Suhocki, Kirk A Ludwig, et al.The American Journal of Gastroenterology|May 15, 2008
Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trialWilliam D Chey, Pierre Paré, Andrea Viegas, et al.Contemporary Clinical Trials|January 18, 2006
Factors motivating dyspepsia patients to enter clinical researchMikhail A Rojavin, Pamela Downs, Michael A Shetzline, et al.The Journal of Biological Chemistry|April 30, 2002
Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestrationMichael A Shetzline, Julia K L Walker, Kenneth J Valenzano, et al.Current Opinion in Investigational Drugs (London, England : 2000)|February 27, 2004
Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal functionMichael D Crowell, Michael A Shetzline, Peter L Moses, et al.The American Journal of Gastroenterology|November 9, 2006
Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipationStefan Müller-Lissner, Michael A Kamm, Ahmet Musoglu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2006
Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivitySheila Rodriguez-Stanley, Sattar Zubaidi, Howard M Proskin, et al.Pageof 1